Members |
targetComponentId |
piperacillin 1 g, pulver till injektionsvätska, flaska |
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
piperacillin 2 g, pulver till injektionsvätska, flaska |
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial |
Piperacillin 3g injection (pdr for recon) |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Piperacillin 4g infusion set |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
piperacillin 4 g, pulver till injektionsvätska, flaska |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
piperacillin 4 g och tazobaktam 500 mg, pulver och vätska till infusionsvätska, flaska |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Piperacillin sodium + tazobactam sodium ns/ns injection |
Product containing piperacillin and tazobactam (medicinal product) |
piperacillinnatrium 3 g, pulver till injektionsvätska, flaska |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Piperacillin sodium 4g powder for injection solution vial |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
piperazin 4 g + sennosider 15,3 mg per dospåse, oralt pulver |
Product containing only piperazine and sennoside (medicinal product) |
biverkning av piperidolathydroklorid |
Adverse reaction to piperidolate (disorder) |
Piple cumanesis cumanesis |
Aburria cumanensis subspecies cumanensis (organism) |
pirbuterolacetat 0,2 mg, aerosol |
Product containing only pirbuterol (medicinal product) |
piroxikam 10 mg, dispergerbar tablett |
Piroxicam 10 mg oral tablet |
piroxikam 20 mg, munsönderfallande tablett |
Piroxicam 20 mg oral tablet |
piroxikam 20 mg, dispergerbar tablett |
Piroxicam 20 mg oral tablet |
piroxikam 20 mg, smälttablett |
Piroxicam 20 mg oral tablet |
hypofysadenom |
Benign pituitary adenoma (morphologic abnormality) |
Pituitary hypothyroidism |
Secondary hypothyroidism |
Pituitary interstitial cell stimulating hormone |
Pituitary luteinizing hormone |
Pityriasis lichenoides chronica |
Chronic lichenoid pityriasis |
Pityriasis lichenoides et varioliformis acuta |
Acute lichenoid pityriasis |
Pityriasis lichenoides et varioliformis of Mucha-Habermann |
Acute lichenoid pityriasis |
Pityrosporum folliculitis |
Malassezia folliculitis (disorder) |
Pityrosporum infection of skin |
Malassezia infection of skin (disorder) |
pizotylin 250 mikrogram/5 ml, elixir |
Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) |
Placement |
Insertion - action (qualifier value) |
Placenta bipartita |
Twin placenta |
Planococcus okeanokoites |
Planomicrobium okeanokoites (organism) |
Plant fiber |
Plant fiber |
Plasma cell leukemia |
Plasma cell leukemia |
plasmacellsmyelom, kategori |
Plasma cell myeloma |
Plasma factor V level |
Clotting factor V assay |
Plasma factor V level |
Clotting factor V assay |
Plasma kallikrein |
Kallikrein |
plasmocytom, kategori |
Plasmacytoma |
Plasmin activator |
Plasminogen activator |
Plasminogen activator |
Plasminogen activator |
Plasminogen inactivator |
Plasminogen activator inhibitor |
gips |
Adhesive plaster |
plåster |
Adhesive plaster |
Platelet precursor |
Megakaryocytic cell |
trombocytsatellit |
Platelet satellite |
Play psychotherapy |
Play therapy |
Pleura endoscopy |
Thoracoscopy |
utgjutning i lungsäck i samband med pankreatit |
Pleural effusion due to pancreatitis (disorder) |
plommon, livsmedel |
Plum (substance) |
Pneumoconiosis due to silicates |
Pneumoconiosis caused by silicate (disorder) |
Pneumocystis carinii DNA |
Pneumocystis jirovecii DNA |
analys avseende Pneumocystis carinii-DNA |
Pneumocystis jirovecii deoxyribonucleic acid assay (procedure) |
Pneumocystis carinii IF |
Pneumocystis jirovecii immunofluorescence (procedure) |
Pneumocystis carinii IF |
Pneumocystis jirovecii immunofluorescence (procedure) |
antigen från Pneumocystis carinii |
Pneumocystis jirovecii antigen |
Pneumocystis carinii antigen assay |
Pneumocystis jirovecii antigen assay (procedure) |
Pneumocystis carinii antigen level |
Pneumocystis jirovecii antigen assay (procedure) |
Pneumocystis carinii antigen level |
Pneumocystis jirovecii antigen assay (procedure) |
Pneumocystis carinii antigen level |
Pneumocystis jirovecii antigen assay (procedure) |
koroidit orsakad av pneumocystis carinii |
Pneumocystis jirovecii choroiditis |
immunfluorescensanalys avseende Pneumocystis carinii |
Pneumocystis jirovecii immunofluorescence (procedure) |
Podophyllin 10% |
Podophyllum resin (substance) |
Podophyllin 20% |
Podophyllum resin (substance) |
Podophyllin 40% |
Podophyllum resin (substance) |
Poephila castanotis |
Taeniopygia guttata (organism) |
Poephila gouldiae |
Chloebia gouldiae (organism) |
Poikilotherm |
Kingdom Animalia (organism) |
Poikilovirus |
Suid herpesvirus 1 |
Poison mushroom |
Order Agaricales |
Poisoning by Centruroides sculpturatus |
Poisoning by Centruroides exilicauda |
Poisoning by acetylsalicylic acid |
Poisoning by salicylate |
Poisoning by acidifying agent |
Poisoning |
Poisoning by anticoagulant antagonist |
Poisoning by anticoagulant antagonist |
Poisoning by antidote or chelating agent, NEC |
Poisoning by antidote AND/OR chelating agent |
Poisoning by antihypertensive agent, NEC |
Poisoning by antihypertensive agent |
Poisoning by antimycobacterial antibiotic |
Poisoning by antimycobacterial drug |
Poisoning by antirheumatic, NEC |
Poisoning by antirheumatic |
Poisoning by arthropod bite |
Poisoning due to arthropod venom |
Poisoning by diuretic, NEC |
Poisoning by diuretic |
Poisoning by drug AND/OR biological |
Poisoning by drug AND/OR medicinal substance |
Poisoning by electrolytic, caloric and water-balanced agent, NEC |
Poisoning by drug AND/OR medicinal substance |
Poisoning by emollient |
Poisoning by emollient cathartic |
Poisoning by enzyme, NEC |
Poisoning by enzyme |
Poisoning by local anesthetic, NEC |
Poisoning caused by local anesthetic (disorder) |
Poisoning by other anticonvulsant, NEC |
Poisoning by anticonvulsant |
Poisoning by other central nervous system stimulant, NEC |
Poisoning by central nervous system stimulant |
Poisoning by other psychotropic agent, NEC |
Poisoning by psychotropic agent |
Poisoning by salicylic acid salt |
Poisoning by salicylate |
Poisoning by tranquilizer, NEC |
Poisoning by tranquilizer |
Poisoning by vasodilator, NEC |
Poisoning by vasodilator |
Poisoning by vitamin, NEC |
Poisoning by vitamin |
förgiftning orsakad av alkaliserande medel |
Poisoning |
förgiftning orsakad av antibiotikum i gruppen kloramfenikoler |
Poisoning by chloramphenicol |
Politzerization - action |
Inflation - action |
polyartikulär juvenil reumatoid artrit |
Polyarticular juvenile idiopathic arthritis |
Polyarticular juvenile rheumatoid arthritis |
Polyarticular juvenile idiopathic arthritis |
Polyarticular onset juvenile chronic arthritis |
Polyarticular juvenile idiopathic arthritis |
Polycythemia neonatorum |
Neonatal polycythemia |
Polycythemia vera |
Polycythemia vera |
polyetylenglykol 3350, 100 %, pulver |
Macrogol 3350 only product |
polymetylmetakrylatmikrosfärer 20 % + bovint kollagen 3,5 %, injektionsvätska, lösning, förfylld spruta |
Product containing only bovine collagen and polymethyl methacrylate (medicinal product) |
polymyxin B-sulfat 500 000 IE, pulver till injektionsvätska, flaska |
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
Polymyxin b sulfate + trimethoprim sulfate |
Product containing polymyxin B and trimethoprim (medicinal product) |